BM
CHRS icon

Bridger Management’s Coherus Oncology CHRS Stock Holding History

Bridger Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-329,345
Closed -$6.97M – 38
2017
Q1 		$6.97M Hold
329,345
– – 0.4% 36
2016
Q4 		$9.27M Sell
329,345
-30,541
-8% -$855K 0.64% 35
2016
Q3 		$9.64M Buy
+359,886
New +$9.82M 0.65% 36
2016
Q2 		– Sell
-341,121
Closed -$7.24M – 39
2016
Q1 		$7.24M Buy
+341,121
New +$5.59M 0.5% 36

Other funds holding CHRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Bridger Management's CHRS Position: Q2 2017 in Review

Bridger Management sold out of Coherus Oncology (CHRS) in Q2 2017, closing a stake of 329,345 shares — an estimated $6.97M sold.

Bridger Management first reported a position in CHRS in Q1 2016 and held it in 4 quarters. The position peaked at $9.64M in Q3 2016. 106 funds tracked by Wall St. Rank hold CHRS as of Q2 2017.

  • Bridger Management reported no remaining Coherus Oncology position as of Q2 2017 after selling out during the quarter.
  • Bridger Management sold 329,345 Coherus Oncology shares in Q2 2017, an estimated $6.97M.
  • Bridger Management first reported a position in Coherus Oncology in Q1 2016 and held it in 4 quarters.
  • Bridger Management's Coherus Oncology position peaked at $9.64M in Q3 2016.
  • 106 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2017.

Based on Bridger Management's 13F filing for Q2 2017, filed 14 Aug 2017.